AGP Picks
View all

Middle East Business Channel
Provided by AGP

Middle East Business Channel: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Business Channel.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 21, 2026

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
NVIDIA Announces Upcoming Events for Financial Community
May 21, 2026

NVIDIA Announces Upcoming Events for Financial Community

Indeterminate GlobeNewswire
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 21, 2026

Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
Canadian Net REIT Announces 2026 First-Quarter Results and a Distribution Increase
May 21, 2026

Canadian Net REIT Announces 2026 First-Quarter Results and a Distribution Increase

Indeterminate GlobeNewswire
FPI Canadien Net annonce ses résultats pour le premier trimestre 2026 et une augmentation de ses distributions
May 21, 2026

FPI Canadien Net annonce ses résultats pour le premier trimestre 2026 et une augmentation de ses distributions

Indeterminate GlobeNewswire
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
May 21, 2026

Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC

Indeterminate GlobeNewswire
Northview Residential REIT Announces May Distribution
May 21, 2026

Northview Residential REIT Announces May Distribution

Indeterminate GlobeNewswire
Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
May 21, 2026

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy

Indeterminate GlobeNewswire
BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting
May 21, 2026

BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash
May 21, 2026

Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash

Indeterminate GlobeNewswire
Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
May 21, 2026

Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline

Indeterminate GlobeNewswire
HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting
May 21, 2026

HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
TruGolf Reports First Quarter 2026 Results
May 21, 2026

TruGolf Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Elevated Roofing Says Recent Weather Rushed New Roof Decisions
May 21, 2026

Elevated Roofing Says Recent Weather Rushed New Roof Decisions

Indeterminate GlobeNewswire
YRC Expands SOP Consulting as 'Paper-Only' Procedures Cripple Mid-Sized Businesses Globally
May 21, 2026

YRC Expands SOP Consulting as 'Paper-Only' Procedures Cripple Mid-Sized Businesses Globally

Indeterminate EIN Presswire
Qatar Emerges as One of the GCC’s Most Competitive Real Estate Markets by Entry Price
May 21, 2026

Qatar Emerges as One of the GCC’s Most Competitive Real Estate Markets by Entry Price

Indeterminate EIN Presswire
ATRARA (NASDAQ:ATRA) DEADLINE MAY 22nd: Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action Lawsuit
May 21, 2026

ATRARA (NASDAQ:ATRA) DEADLINE MAY 22nd: Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action Lawsuit

Indeterminate GlobeNewswire
COTY CLASS ACTION DEADLINE TOMORROW MAY 22nd: Bragar Eagel & Squire, P.C. Urges Coty, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 22nd
May 21, 2026

COTY CLASS ACTION DEADLINE TOMORROW MAY 22nd: Bragar Eagel & Squire, P.C. Urges Coty, Inc. Stockholders with Significant Losses to Contact the Firm Regarding Their Rights Before May 22nd

Indeterminate GlobeNewswire
The Math Underlying the Success of Tort Reforms – Florida Property Insurance and Beyond
May 21, 2026

The Math Underlying the Success of Tort Reforms – Florida Property Insurance and Beyond

Indeterminate GlobeNewswire
CVB Financial Corp. Names George A. Borba Jr. Chairman of the Board; Prior Chairman Hal W. Oswalt Transitions to Vice Chairman
May 21, 2026

CVB Financial Corp. Names George A. Borba Jr. Chairman of the Board; Prior Chairman Hal W. Oswalt Transitions to Vice Chairman

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Business Channel

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.